Becker's Hospital Review - Cardiology

FEBRUARY 16, 2024

When patients awaiting crucial heart transplants are placed on the organ transplant waiting list, they've traditionally been arranged based on what type of treatments they were receiving for their current condition. But researchers from the University of Chicago have discovered a new, more accurate way to rank patients.

Heart Transplant 65

Heart Transplant Transplant Research 65

Becker's Hospital Review - Cardiology

MAY 28, 2024

Researchers at Atlanta-based Emory University developed artificial intelligence that they say improves the prediction of successful heart transplants by 10%.

Heart Transplant 52

Heart Transplant Transplant Research 52

Journal of Cardiothoracic Surgery

JULY 24, 2024

Lung transplantation (LT) represents a high-risk procedure for end-stage lung diseases. This study describes the outcomes of patients undergoing LT that require massive transfusions as defined by the universal.

Transplant 52

Transplant Outcomes Research 52

Journal of Cardiothoracic Surgery

FEBRUARY 9, 2024

We examine the factors associated with heart transplant outcomes in this challenging population with complex anatomy requiring redo-sur. Adult patients surviving with congenital heart disease (ACHD) is growing.

Congenital Heart Disease 52

Congenital Heart Disease Heart Transplant Transplant Congenital 52

Circulation

MARCH 11, 2024

Hematopoietic stem cell transplantation can cure various disorders but poses cardiovascular risks, especially for elderly patients and those with cardiovascular diseases. Cardiovascular evaluations are crucial in pretransplantation assessments, but guidelines are lacking.

Transplant 45

Transplant Cardiovascular Disease Atrial Fibrillation Pediatrics 45

Frontiers in Cardiovascular Medicine

MAY 29, 2024

BackgroundMesenchymal stem cells (MSCs) have important research value and broad application prospects in cardiovascular diseases (CVDs). Importantly, current research trends and hotspots are elucidated. Besides, keywords analysis revealed a strong emphasis on myocardial infarction, therapy, and transplantation.

Cardiovascular Disease 52

Cardiovascular Disease Research Myocardial Infarction Article 52

HCPLive

SEPTEMBER 5, 2024

Host Veeral Sheth, MD is joined by John Sheets, PhD, the president, CEO, and co-founder of Pantheon Vision, an early research-stage organization working to develop bioengineered solutions to eliminate corneal blindness.

Transplant 59

Transplant Research 59

Cardiovascular Diabetology

JUNE 20, 2024

Pretransplant type 2 diabetes mellitus (T2DM) is associated with increased cardiovascular and all-cause mortality after heart transplant (HT), but the underlying causes of this association remain unclear.

Heart Transplant 52

Heart Transplant Transplant Diabetes Research 52

Science Daily - Heart Disease

APRIL 26, 2024

Regenerative heart therapies involve transplanting cardiac muscle cells into damaged areas of the heart to recover lost function. In a recent study, researchers tested a novel approach that involves injecting 'cardiac spheroids,' cultured from human stem cells, directly into damaged ventricles.

Transplant 121

Transplant Arrhythmia Research Outcomes 121

Science Daily - Heart Disease

JUNE 10, 2024

Having explored how the heart is formed in utero, a researcher is reporting how cells and molecules act during that early formation and what might cause the heart disease called left ventricular non-compaction or spongy heart, for which patients often require heart transplants.

Heart Disease 91

Heart Disease Heart Transplant Transplant Research 91

HCPLive

JULY 26, 2024

New research suggests combined treatment with fecal microbiota transplant and anti-PD-1 inhibitors may help overcome immune checkpoint inhibitor resistance in gastrointestinal cancers.

Cancer 59

Cancer Transplant Research 59

Journal of Cardiothoracic Surgery

DECEMBER 7, 2023

Lung transplantation is the only life-saving treatment for lung diseases that do not respond to medical treatment. Heart-lung harvesting requires a careful procedure to protect an adequate donor left atrial cu.

Transplant 40

Transplant Research 40

DAIC

FEBRUARY 21, 2024

As the only pediatric heart transplant program in Louisiana and the only program in the state to offer advanced mechanical support options for pediatric cardiology patients, Ochsner Children’s Hospital is committed to advocating for additional medical devices to enhance its high-quality care to pediatric patients awaiting transplant.

Pediatrics 105

Pediatrics Hospital Heart Failure Transplant 105

DAIC

JUNE 24, 2024

Kittleson, director of Heart Failure Research and director of Post Graduate Medical Education in Heart Failure and Transplantation, is an associate editor specializing in heart failure. Gupta, an interventional and structural cardiologist, is one of the journal’s new executive associate editors.

Heart Failure 100

Heart Failure Transplant Research Heart Valves 100

DAIC

APRIL 30, 2024

Image courtesy of Hideki Kobayashi from Shinshu University milla1cf Tue, 04/30/2024 - 12:53 April 30, 2024 — Regenerative heart therapies involve transplanting cardiac muscle cells into damaged areas of the heart to recover lost function. However, the risk of arrhythmias following this procedure is reportedly high.

Transplant 105

Transplant Heart Transplant Myocardial Infarction Heart Attack 105

Med Page Today

FEBRUARY 13, 2024

(MedPage Today) -- To more fairly rank candidates for heart transplant, researchers developed the U.S. candidate risk score (US-CRS) and found it to better discriminate risk for people with advanced heart failure than the current six-status system.

Heart Transplant 65

Heart Transplant Transplant Heart Failure Research 65

Cardiology Update

APRIL 25, 2024

The primary endpoint was a composite of all-cause mortality, left ventricular assist device (LVAD)/heart transplantation, HF hospitalizations, worsening HF, and KCCQ score changes. For more cardiology research news join our newsletter or follow us on Twitter , Facebook , LinkedIn or Instagram. Reference: Stone GW.

Heart Failure 98

Heart Failure Heart Transplant Transplant Research 98

Heart 2023 Conference

JANUARY 17, 2024

This institute is dedicated to pioneering research, innovation, and the development of clinically effective techniques for addressing various heart conditions. Read more and share the research work at [link]

Congenital Heart Disease 49

Congenital Heart Disease Coronary Artery Disease Heart Transplant Transplant 49

DAIC

MARCH 8, 2024

The research is funded by a four-year, $7.8 million grant awarded to Georgia Tech by the United States Department of Defense Congressionally Directed Medical Research Programs (CDMRP) as part of the agency’s call for the development of less invasive treatment technologies for cardiovascular conditions associated with cardiomyopathy.

Blood Clot 98

Blood Clot Heart Failure Quality of Life Innovation 98

Stroke Journal

FEBRUARY 1, 2024

Introduction:Intraparenchymal stem cell transplantation shows therapeutic promise for chronic ischemic stroke patients. Visium identified specific gene clusters for the stroke injury, transplant/needle-track, stem cell graft, and the cortical ‘FLAIR’ region. Stroke, Volume 55, Issue Suppl_1 , Page ATP286-ATP286, February 1, 2024.

Transplant 40

Transplant Stroke Strokes Research 40

DAIC

FEBRUARY 22, 2024

Researchers Elizabeth Jordan and Ray Hershberger, MD discuss the results of genetic tests that indicate a risk for dilated cardiomyopathy. heart failure/heart transplant programs that contributed to the study. He was senior author of the study which published in the Journal of the American Medical Association.

Heart Failure 104

Heart Failure Sudden Cardiac Death Heart Transplant Cardiomyopathy 104

DAIC

MARCH 6, 2024

Food and Drug Adminstration (FDA) has approved DEFINITY (Perflutren Lipid Microsphere) as an ultrasound enhancing agent for use in pediatric patients with suboptimal echocardiograms, including those who have undergone heart transplant, or have Kawasaki disease or a congenital cardiovascular anomaly. 3 ©2021 Millennium Research Group, Inc.

Pediatrics 105

Pediatrics Ultrasound Heart Transplant Echocardiogram 105

Cardiology Update

JANUARY 22, 2024

The primary outcome was death from any cause, and the secondary outcome included a composite of death, heart transplantation, or ventricular assist device implantation. For more cardiology research news join our newsletter or follow us on Twitter , Facebook , LinkedIn or Instagram. Original article: Sapp JL et al.

Heart Failure 115

Heart Failure Defibrillator Heart Transplant Transplant 115

Cardiometabolic Health Congress

MAY 3, 2024

30 years of pioneering research in liver diseases Over a distinguished 30-year career, Dr. Harrison led groundbreaking research in liver diseases, notably focusing on advancing treatment options for metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH).

Education 59

Education Research Pharmacology Transplant 59

DAIC

APRIL 16, 2024

William Abraham of the Ohio State Wexner College of Medicine presented analysis showing that patients in the trial with Barostim + GDMT had a 74% reduced risk of receiving advanced heart failure interventions (transplant, LVAD, CCM, CRT or CardioMEMS) at long-term follow-up versus patients on GDMT alone. See more details at TCTMD.

Heart Failure 104

Heart Failure Quality of Life Transplant Heart Transplant 104

DAIC

FEBRUARY 2, 2024

The event is offered as an interdisciplinary and interspecialty course to provide clinicians and researchers with the tools needed to improve the cardiovascular (CV) health of cancer patients in everyday practice. 9-11, 2024. 9-11, 2024, with program planners preparing a robust program. The opening Plenary session, “Perspective from the U.S.

Cardio Oncology 95

Cardio Oncology Cancer Pharmacology RN 95

DAIC

DECEMBER 8, 2023

The study also includes a registry for advanced heart failure patients who are end stage and not considered to be surgical candidates for a heart transplant or left ventricular assist device (LVAD) implant due to excessive fluid retention and poor kidney function. Fain, MD , President and Chief Executive Officer, Procyrion. "We

Technology 113

Technology Heart Failure Heart Transplant Transplant 113

Journal of Cardiothoracic Surgery

FEBRUARY 15, 2024

This study investigates the efficacy of using a long-acting insulin analog, along with the infusion of regular insulin, in achieving appropriate glycemic control and correcting lactic acidosis in patients post.

Heart Transplant 52

Heart Transplant Transplant Research 52

Society of Thoracic Surgeons - Research

MAY 5, 2023

About Annals of Thoracic Surgery Short Reports Annals of Thoracic Surgery Short Reports —the official fully open access companion journal to The Annals of Thoracic Surgery —provides a modern venue for authors to present their research in a digestible format, while also making it available immediately, permanently, and universally.

Article 52

Article Cardiothoracic Education Congenital 52

DAIC

FEBRUARY 13, 2024

THE TEXAS HEART INSTITUTE 2024 milla1cf Tue, 02/13/2024 - 17:56 February 13, 2024 — Pediatric heart transplantation has long been hailed as a life-saving intervention for children suffering from end-stage heart failure. The research, led by esteemed physician-scientist at The Texas Heart Institute ( THI ), Dr. James F.

Transplant 111

Transplant Pediatrics Heart Transplant Research 111

Society of Thoracic Surgeons - Technology

JANUARY 19, 2022

With her fellowship, Dr. Fiedler plans to learn skills and administrative approaches that will help her expand the heart transplant program at UW-Madison, where she currently serves as associate director of heart transplantation and mechanical circulatory support. Kennedy, TSF Executive Director, pkennedy@sts.org, 312-202-5868.

Cardiothoracic 52

Cardiothoracic Heart Transplant Allied Health Education 52

DAIC

MARCH 13, 2024

The CardiAMP clinical development for heart failure is supported by the Maryland Stem Cell Research Fund and is reimbursed by CMS for both treatment and control procedures. The study includes an eligibility requirement that patients demonstrate a pre-specified NT-proBNP level at baseline.

CMS 111

CMS Heart Failure Reimbursement Quality of Life 111

DAIC

MARCH 13, 2024

In July 2021, Atlantic Health System and NYU Langone Health announced their partnership on organ transplantation that coordinates transplant care at Morristown Medical Center for heart patients and Overlook Medical Center for liver patients allowing greater access through a high-quality and highly collaborative patient care team.

Congenital Heart Disease 52

Congenital Heart Disease Congenital Heart Disease Cancer 52

European Journal of Heart Failure

DECEMBER 13, 2023

CV, cardiovascular; HT, heart transplantation; ICU, intensive care unit; LVAD, left ventricular assist device. The primary endpoint was the rate of weaning from VA-ECMO during index admission. The early LV unloading strategy did not increase the weaning rate from VA-ECMO compared with the conventional approach.

Aortic valve 75

Aortic valve Cardiac Arrest Heart Transplant Pulmonary 75

European Journal of Heart Failure

OCTOBER 3, 2023

CV mortality is the composite endpoint for CV mortality + urgent transplant + left ventricular assist device implantation. The primary endpoint of the study was the composite of cardiovascular death, left ventricular assist device implantation, and urgent heart transplantation. Events per 1000 person-years. #

Heart Failure 40

Heart Failure Exercise Laboratory Transplant 40

Open Heart

MAY 25, 2022

The secondary outcome was the TE and mortality and heart transplantation rates between paediatric and adult patients with LVNC. Studies that did not present original research, non-human studies, duplicated studies were excluded. Methods The primary outcome was the prevalence and incidence of TE in the patients with LVNC.

Heart Transplant 40

Heart Transplant Transplant Risk Factors Outcomes 40

Frontiers in Cardiovascular Medicine

JANUARY 23, 2024

Introduction Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in kidney transplant recipient (KTR). There is a dearth of standardized guidelines on optimal cardiovascular evaluation of transplant candidates. were found to have obstructive coronary artery disease (CAD).

Transplant 64

Transplant Coronary Artery Disease Myocardial Infarction Cardiovascular Disease 64